Abstract
ObjectivesThis study aimed to develop a liquid oral formulation containing losartan potassium, an angiotensin II receptor antagonist drug used for its antihypertensive activity, and to perform a preliminary stability assessment...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have